Sodium cridanimod
Sponsors
Kevelt AS, Xenetic Biosciences, Inc.
Conditions
Endometrial CancerRecurrent or Persistent Endometrial Carcinoma
Phase 2
Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
NCT02064725
Start: 2014-09-30End: 2018-07-31Updated: 2017-01-24
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
TerminatedNCT03077698
Start: 2017-06-14End: 2020-07-17Updated: 2022-06-07